Search by Drug Name or NDC
NDC 60505-4696-01 Penicillamine 250 mg/1 Details
Penicillamine 250 mg/1
Penicillamine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is PENICILLAMINE.
MedlinePlus Drug Summary
Penicillamine is used to treat Wilson's disease (an inherited condition that causes copper to build up in the body and may result in serious symptoms) and cystinuria (an inherited condition which can lead to kidney stones). It is also used in combination with other treatments to treat severe rheumatoid arthritis (a condition in which the body's immune system attacks its own joints, causing pain, swelling, and loss of function) that did not get better after treatment with other medications. Penicillamine is in a class of medications called heavy metal antagonists. It works to treat Wilson's disease by binding to the extra copper in the body and causing it to leave the body through the urine. It works to treat cystinuria by binding to the substance that makes kidney stones and preventing it from building up and forming stones. It works to treat rheumatoid arthritis by decreasing some actions of the immune system.
Related Packages: 60505-4696-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Penicillamine
Product Information
| NDC | 60505-4696 |
|---|---|
| Product ID | 60505-4696_dc5730d7-2909-9e52-4377-df3b8bd6902c |
| Associated GPIs | 99200030000110 |
| GCN Sequence Number | 002542 |
| GCN Sequence Number Description | penicillamine CAPSULE 250 MG ORAL |
| HIC3 | S2K |
| HIC3 Description | ANTI-ARTHRITIC AND CHELATING AGENTS |
| GCN | 07091 |
| HICL Sequence Number | 001103 |
| HICL Sequence Number Description | PENICILLAMINE |
| Brand/Generic | Generic |
| Proprietary Name | Penicillamine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Penicillamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | PENICILLAMINE |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Antirheumatic Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213310 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-4696-01 (60505469601)
| NDC Package Code | 60505-4696-1 |
|---|---|
| Billing NDC | 60505469601 |
| Package | 100 CAPSULE in 1 BOTTLE (60505-4696-1) |
| Marketing Start Date | 2020-06-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |